Nikolai A Podoltsev (Nikolai Podoltsev)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Highly Efficient

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica M Stempel, Rory Michael Shallis, Rong Wong, Nikolai A Podoltsev
Challenges in management of older patients with chronic myeloid leukemia. Leukemia & lymphoma 65 (9) (2024)
Jessica M Stempel, Rory Michael Shallis, Rong Wong, Nikolai A Podoltsev
Challenges in management of older patients with chronic myeloid leukemia. Leukemia & lymphoma (2024)
Jessica M Stempel, Rory Michael Shallis, Rong Wong, Nikolai A Podoltsev
Challenges in management of older patients with chronic myeloid leukemia. Leukemia & lymphoma 65 (9) (2024)
Nikolai A Podoltsev, Rong Wang, Rory Michael Shallis, Jessica M Stempel, Mengyang Di, Natalia Neparidze, Amer M Zeidan, Scott F Huntington, Smith Giri, Sarah C Hull, Steven D Gore, Xiaomei Ma
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia. Cancer medicine (2023)
Keith W Pratz, Mohamad Cherry, Jessica K Altman, Brenda W Cooper, Nikolai A Podoltsev, Jose Carlos Cruz, Tara L Lin, Gary J Schiller, Joseph G Jurcic, Adam Asch, Ruishan Wu, Jason E Hill, Stanley C Gill, Angela J James, Elizabeth Shima Rich, Nahla Hasabou, Alexander E Perl, Mark J Levis
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guillermo Garcia Manero, Nikolai A Podoltsev, Megan K D Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litzow, M Lynn Savoie, Bruno C Medeiros, Mikkael A Sekeres, Tara L Lin, Geoffrey L Uy, Bayard L Powell, Jonathan E Kolitz, Richard A Larson, Richard M Stone, David F Claxton, James Essell, Selina M Luger, Sanjay R Mohan, Anna B Moseley, Frederick R Appelbaum, Harry P Erba
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. Leukemia (2023)
Rory Michael Shallis, Rong Wang, Amer M Zeidan, Scott F Huntington, Natalia Neparidze, Jessica M Stempel, Lourdes M Mendez, Mengyang Di, Xiaomei Ma, Nikolai A Podoltsev
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence. Blood advances (2023)
Rong Wang, Rory Michael Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan, Steven D Gore, Xiaomei Ma, Nikolai A Podoltsev
Second Malignancies among Older Patients with Classical Myeloproliferative Neoplasms Treated with Hydroxyurea. Blood advances (2022)
Natalia Neparidze, Rong Wang, Amer M Zeidan, Nikolai A Podoltsev, Rory Michael Shallis, Xiaomei Ma, Amy J Davidoff, Scott F Huntington
Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period. Leukemia 36 (8) (2022)
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Recher, Sung Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee-Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramon Tiu, Mark J Levis
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood 139 (23) (2022)
Mengyang Di, Can Cui, Shalin K Kothari, Amer M Zeidan, Nikolai A Podoltsev, Natalia Neparidze, Rory Michael Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis. Blood advances 6 (11) (2022)
Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory Michael Shallis, Nikolai A Podoltsev, Scott F Huntington, Amer M Zeidan
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia. Blood 139 (11) (2022)
Alexander E Perl, Naoko Hosono, Pau Montesinos, Nikolai A Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C Smith, Mark J Levis, Stephen A Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V Tiu, Jessica K Altman
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib. Blood cancer journal 12 (5) (2022)
Talha Badar, Aniko Szabo, Mark R Litzow, Madelyn Burkart, Ilana Yurkiewicz, Shira Dinner, Mehrdad Hefazi, Rory M Shallis, Nikolai A Podoltsev, Anand A Patel, Emily Curran, Martha Wadleigh, Suresh Balasubramanian, Jay Yang, Shukaib Arslan, Ibrahim Aldoss, Ryan Mattison, Danielle Cenin, Caitlin Siebenaller, Anjali Advani, Michaela Liedtke, Ehab Atallah
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data. Bone marrow transplantation 56 (8) (2021)
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A Podoltsev, Rory Michael Shallis, Scott F Huntington, Natalia Neparidze, Rong Wang, Amer M Zeidan, Amy J Davidoff
Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia in the United States. Blood advances (2021)
Rory M Shallis, Nikolai A Podoltsev
Emerging agents and regimens for polycythemia vera and essential thrombocythemia. Biomarker research 9 (1) (2021)
Talha Badar, Aniko Szabo, Shira Dinner, Michaela Liedtke, Madelyn Burkart, Rory M Shallis, Ilana R Yurkiewicz, Eric Kuo, Muhammad Ali Khan, Suresh Balasubramanian, Jay Yang, Mehrdad Hefazi, Nikolai A Podoltsev, Anand Ashwin Patel, Emily Curran, Amy Wang, Shukaib Arslan, Ibrahim Aldoss, Caitlin Siebenaller, Ryan J Mattison, Mark R Litzow, Martha Wadleigh, Anjali S Advani, Ehab Atallah
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Cancer 127 (7) (2020)
Maximilian Stahl, Rory Michael Shallis, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen, Vijaya R Bhatt, Mikkael A Sekeres, Amir T Fathi, Heiko Konig, Selina M Luger, Irum Khan, Gail J Roboz, Thomas Cluzeau, David Martínez-Cuadron, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukherjee, Andrew M Brunner, Adam Miller, Christine M McMahon, Ellen K Ritchie, Rebeca Rodríguez-Veiga, Raphaël A Itzykson, Blanca Boluda, Florence Rabian, Mar Tormo, Evelyn Acuña-Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A Podoltsev, Jan Philipp Bewersdorf, Steven Gore, Amer M Zeidan
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia 34 (12) (2020)
Hadrian Mendoza, Po-Han Chen, Alexander B Pine, Alexa J Siddon, Allen E Bale, Lohith Gowda, Amy Killie, Jonica Richards, Camille Varin-Tremblay, Robert Kloss, Nikolai A Podoltsev
A case of acute myeloid leukemia with unusual germline CEBPA mutation: lessons learned about mutation detection, location, and penetrance. Leukemia & lymphoma 62 (5) (2020)
Jan Philipp Bewersdorf, Smith Giri, Rong Wang, Nikolai A Podoltsev, Robert T Williams, Martin S Tallman, Raajit K Rampal, Amer M Zeidan, Maximilian Stahl
Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis. Leukemia 35 (6) (2020)
Nikolai A Podoltsev, Xiaoyi Wang, Rong Wang, Jonathan N Hofmann, Linda M Liao, Amer M Zeidan, Ruben A Mesa, Xiaomei Ma
Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (11) (2020)
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, Jan Philipp Bewersdorf, Rory M Shallis, Scott F Huntington, Steven D Gore, Amy J Davidoff, Xiaomei Ma, Rong Wang
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis. Cancer 125 (23) (2019)
Yuan-Bin Song, Anthony Rongvaux, Ashley Taylor, Tingting Jiang, Toma Tebaldi, Kunthavai Balasubramanian, Arun Bagale, Yunus Kasim Terzi, Rana Gbyli, Xiaman Wang, Xiaoying Fu, Yimeng Gao, Jun Zhao, Nikolai A Podoltsev, Mina Xu, Natalia Neparidze, Ellice Wong, Richard Torres, Emanuela M Bruscia, Yuval Kluger, Markus Gabriel Manz, Richard A Flavell, Stephanie Halene
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies. Nature communications 10 (1) (2019)
Amer M Zeidan, Maximilian Stahl, Michelle DeVeaux, Smith Giri, Scott Huntington, Nikolai A Podoltsev, Rong Wang, Xiaomei Ma, Amy J Davidoff, Steven D Gore
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates? Blood cancer journal 8 (6) (2018)